Liraglutide

theater stage with red curtains and spotlights
Research

GLP-1 liraglutide reduces cognitive decline in Alzheimer's

The trial failed its primary endpoint, but met secondary endpoints of slower loss of brain volume and slower cognitive decline.
Darren Incorvaia Jul 30, 2024 1:29pm
victoza

GLP-1 drug hydrogels could reduce shots to 3 times a year

Nov 28, 2023 11:30am
Obesity

Saxenda's appetite-cutting ability may inspire new obesity drugs

Mar 5, 2020 7:32am